These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression. Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396 [TBL] [Abstract][Full Text] [Related]
24. Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection. Katzenstein DA AIDS Read; 2008 Sep; 18(9):478-9. PubMed ID: 18828232 [No Abstract] [Full Text] [Related]
25. The XIV International AIDS Conference. What's new in drug regimens? Clifton CE Posit Aware; 2002; 13(5):27-9. PubMed ID: 12400488 [No Abstract] [Full Text] [Related]
26. Fosamprenavir: a new PI option. Interview by Craig Sterritt. Nadler J IAPAC Mon; 2004 Feb; 10(2):50-2. PubMed ID: 15106520 [No Abstract] [Full Text] [Related]
27. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase. TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608 [No Abstract] [Full Text] [Related]
28. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection. Wilkins E J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268 [No Abstract] [Full Text] [Related]
29. Antiretroviral rounds. Resistance: what you don't know--can it hurt you? Gathe JC; Elion R AIDS Clin Care; 2008 Jun; 20(6):51-2. PubMed ID: 18661634 [No Abstract] [Full Text] [Related]
34. Anti-HIV agents. Atazanavir as a booster for protease inhibitors. TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850 [No Abstract] [Full Text] [Related]
35. Current concepts in antiretroviral therapy failure. del Rio C Top HIV Med; 2006; 14(3):102-6. PubMed ID: 16946454 [TBL] [Abstract][Full Text] [Related]
36. Substitution for protease inhibitors in HIV therapy. Mikhail E N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602 [No Abstract] [Full Text] [Related]
38. Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004. Lohse N; Obel N; Kronborg G; Jørgensen LB; Pedersen C; Larsen CS; Kvinesdal B; Sørensen HT; Gerstoft J Antivir Ther; 2006; 11(5):591-600. PubMed ID: 16964827 [TBL] [Abstract][Full Text] [Related]
39. Popping pills for life. Focus; 1998 Feb; 13(3):5-6. PubMed ID: 11365169 [TBL] [Abstract][Full Text] [Related]
40. New fixed-dose once-a-day starting regimens: interview with Cal Cohen, M.D. Interview by John S. James. Cohen C AIDS Treat News; 2004 Sep; (405):3-6. PubMed ID: 15595150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]